Charla: 'Scientific Publications and its Effects on Research Integrity'
Impartida por: Professor Patrick Chien, MBChB (Dundee), MD (Dundee) FRCOG
Día: 30 de septiembre de 2024
Lugar: Salón de Grados B
Hora: 16:30 horas
Biografía
-------------------
Professor Patrick Chien has an active research in integrity of randomised controlled trials and previously has published systematic reviews on diagnostic tests as well as interventional studies.
He previously worked as a Consultant/ Honorary Senior Lecturer in Obstetrics and Gynaecology at Ninewells Hospital and Medical School, Dundee, Scotland, UK.
His special interests are in minimal access surgery dealing in menstrual dysfunction and chronic pelvic pain. He has also established the out-patient hysteroscopy service there for diagnostic and therapeutic procedures. He was the Clinical Director of the Scottish Hydatidiform Mole Follow up Service where all cases of gestational trophoblastic disease in Scotland are referred to Dundee for follow up and further management.
Having retired from the NHS in Scotland, he then took up an appointment as Professor and Head of Department of Obstetrics and Gynaecology at Royal College of Surgeons of Ireland (RCSI) and University College Dublin (UCD) Malaysia Campus (RUMC) in Penang, Malaysia teaching undergraduate medicine. He is currently an Honorary Professor at RUMC.
He previously was a member of the Scottish Committee of the RCOG and he has also examined for the Part III MRCOG examination. He was also the course convener and member of the teaching faculty for the Laparoscopic and Hysteroscopic Surgical Course for Gynaecologists at the Dundee Institute of Healthcare Simulation at the University of Dundee. He still teach on these courses on an honorary basis.
His MD thesis was on maternal and fetal amino acid metabolism and protein turnover during normal pregnancy studied using stable isotopically labelled amino acids.
He currently also serves as the Deputy Editor-in-Chief of the British Journal of Obstetrics & Gynaecology (BJOG) and UK HTA and Scottish CSO funded trials as member of trial steering and data monitoring committees.